Low- and high-level transgenic expression of β2-adrenergic receptors differentially affect cardiac hypertrophy and function in Gαq-overexpressing mice

被引:182
作者
Dorn, GW
Tepe, NM
Lorenz, JN
Koch, WJ
Liggett, SB
机构
[1] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Coll Med, Dept Pharmacol, Cincinnati, OH 45267 USA
[3] Univ Cincinnati, Coll Med, Dept Physiol, Cincinnati, OH 45267 USA
[4] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
关键词
D O I
10.1073/pnas.96.11.6400
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Transgenic overexpression of G alpha q in the heart triggers events leading to a phenotype of eccentric hypertrophy, depressed ventricular function, marked expression of hypertrophy-associated genes, and depressed beta-adrenergic receptor (beta AR) function. The role of beta AR dysfunction in the development of this failure phenotype was delineated by transgenic coexpression of the carboxyl terminus of the beta AR kinase (beta ARK), which acts to inhibit the kinase, or concomitant overexpression of the beta(2)AR at low (approximate to 30-fold, G alpha q/beta(2)AR(L)), moderate (approximate to 140-fold, G alpha q/beta(2)AR(M)), and high (approximate to 1,000-fold, G alpha q/beta(2)AR(H)) levels above background beta AR density. Expression of the beta ARK inhibitor had no effect on the phenotype, consistent with the lack of increased beta ARK levels in G alpha q mice. In marked contrast, G alpha q/beta(2)AR(L) mice displayed rescue of hypertrophy and resting ventricular function and decreased cardiac expression of atrial natriuretic factor and alpha-skeletal actin mRNA. These effects occurred in the absence of any improvement in basal or agonist-stimulated adenylyl cyclase (AC) activities in crude cardiac membranes, although restoration of a compartmentalized beta(2)AR/AC signal cannot be excluded. Higher expression of receptors in G alpha q/beta(2)AR(M) mice resulted in salvage of AC activity, but hypertrophy, ventricular function, and expression of fetal genes were unaffected or worsened. With approximate to 1,000-fold overexpression, the majority of G alpha q/beta(2)AR(H) mice died with cardiomegaly at 5 weeks. Thus, although it appears that excessive, uncontrolled, or generalized augmentation of X AR signaling is deleterious in heart failure, selective enhancement by overexpressing the beta(2)AR subtype to limited levels restores not only ventricular function but also reverses cardiac hypertrophy.
引用
收藏
页码:6400 / 6405
页数:6
相关论文
共 29 条
  • [1] Enhanced Gαq signaling:: A common pathway mediates cardiac hypertrophy and apoptotic heart failure
    Adams, JW
    Sakata, Y
    Davis, MG
    Sah, VP
    Wang, YB
    Liggett, SB
    Chien, KR
    Brown, JH
    Dorn, GW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) : 10140 - 10145
  • [2] Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy
    Akhter, SA
    Luttrell, LM
    Rockman, HA
    Iaccarino, G
    Lefkowitz, RJ
    Koch, WJ
    [J]. SCIENCE, 1998, 280 (5363) : 574 - 577
  • [3] BRISTOW MR, 1989, MOL PHARMACOL, V35, P295
  • [4] DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS
    BRISTOW, MR
    GINSBURG, R
    MINOBE, W
    CUBICCIOTTI, RS
    SAGEMAN, WS
    LURIE, K
    BILLINGHAM, ME
    HARRISON, DC
    STINSON, EB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) : 205 - 211
  • [5] Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase
    Choi, DJ
    Koch, WJ
    Hunter, JJ
    Rockman, HA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) : 17223 - 17229
  • [6] Switching of the coupling of the beta(2)-adrenergic receptor to different G proteins by protein kinase A
    Daaka, Y
    Luttrell, LM
    Lefkowitz, RJ
    [J]. NATURE, 1997, 390 (6655) : 88 - 91
  • [7] Transgenic G alpha q overexpression induces cardiac contractile failure in mice
    DAngelo, DD
    Sakata, Y
    Lorenz, JN
    Boivin, GP
    Walsh, RA
    Liggett, SB
    Dorn, GW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) : 8121 - 8126
  • [8] ASSESSMENT OF THE BETA-ADRENERGIC-RECEPTOR PATHWAY IN THE INTACT FAILING HUMAN-HEART - PROGRESSIVE RECEPTOR DOWN-REGULATION AND SUBSENSITIVITY TO AGONIST RESPONSE
    FOWLER, MB
    LASER, JA
    HOPKINS, GL
    MINOBE, W
    BRISTOW, MR
    [J]. CIRCULATION, 1986, 74 (06) : 1290 - 1302
  • [9] GREEN SA, 1994, J BIOL CHEM, V269, P26215
  • [10] GREEN SA, 1992, MOL PHARMACOL, V41, P889